Forget JEPI: These 3 Covered Call ETFs Yield Over 10% With Less NAV Erosion

The article highlights three covered call ETFs yielding above 9% with positive NAV appreciation since inception: GPIQ at 9.76% and +56.67% NAV change, QDVO at 10.19% and +24.75%, and RSPA at 9.18% and +9.01%. GPIQ posted a 36.36% trailing 1-year return and $3.72B in assets, while QDVO returned 32.68% with the highest yield, though also the highest 0.56% expense ratio. The piece is broadly constructive on covered call ETFs that appear to be generating income without eroding principal.

Analysis

The key second-order read is that these products are not just income wrappers; they are effectively monetization vehicles for crowded large-cap factor exposure. As long as mega-cap growth remains the market’s marginal source of index returns, the option premium is being harvested from a structurally bid underlying, which is why the NAV profiles can stay constructive. That favors the funds built on NVDA/AAPL/MSFT/AMZN/GOOGL exposure, but it also means the income stream is implicitly short upside convexity in the same names that have been doing the heavy lifting for the market.

The more interesting competitive dynamic is that these ETFs may become a liquidity sink for passive flow. Investors reaching for 9%+ monthly distributions can keep re-allocating from lower-yield index funds into covered-call wrappers, which mechanically reduces demand for plain-vanilla beta and increases demand for the very stocks in the overlay baskets. That creates a feedback loop: strong large-cap tech performance supports higher option premia, which supports distributions, which attracts more assets. The risk is that once realized volatility compresses or a sharp rally extends beyond strike discipline, the premium engine weakens just when investor expectations for yield have been reset higher.

The main tail risk is a sudden regime shift in rates or vol. If the market moves into a lower-rate, lower-vol breakout phase, these funds can underperform because investors are paying away upside in names with the highest secular beta; if rates back up, the apparent yield becomes less competitive versus cash and short-duration credit, and flows could reverse over a 1-3 month horizon. The equal-weight product has the cleanest diversification story, but it is also the most exposed to continued mega-cap leadership underperformance relative to cap-weighted benchmarks, so its ‘safety’ pitch is only compelling in a broadening tape.

The contrarian view is that the market may be overpaying for headline yield and underestimating opportunity cost. In a tape where NVDA and peers can gap 10% in days, capping upside for a 9%-10% annual payout can be a poor exchange unless the investor truly needs monthly income. The better risk/reward may be owning the underlying leaders and selectively selling calls into spikes, rather than outsourcing convexity to a permanent wrapper.

Key Decisions for Investors

• Long GPIQ vs. short a broad Nasdaq beta proxy on 1-3 month horizon: express a view that option premium monetization will outperform if tech stays range-bound, but cover quickly if NVDA/AAPL/MSFT start trending on a breakout.
• Use QDVO as a tactical income sleeve only after 2-3 week volatility spikes; buy on pullbacks when implied vol is elevated and sell into calm periods, since the payoff is best when call premia are rich.
• Avoid sizing RSPA as a core substitute for cap-weighted equity until market breadth improves; pair a small long in RSPA against a short QQQ if you expect mega-cap leadership to fade over the next quarter.
• For income mandates, prefer holding the underlying mega-cap basket and overwriting 25%-50% of exposure directly rather than buying the wrappers, preserving upside while still harvesting premium.
• If 10-year yields fall and VIX compresses below recent averages, trim covered-call ETF exposure by 20%-30% because the forward yield advantage versus cash and short-duration credit will narrow quickly.